Majority of Global Employers Remain Unprepared for Pay Transparency Laws, Aon Finds
Organizations remain focused on compliance rather than embracing transparency as a strategic…
Xinhua Silk Road: Ningxia goji berries claim over 61 pct of China’s online retail sales market in 2024
BEIJING, July 11, 2025 /PRNewswire/ -- The online retail sales value of goji…
2025 Kia Telluride ranks number one in its segment in J.D. Power 2025 U.S. Initial Quality Study (IQS)
Kia’s Award-Winning Three-Row SUV Earns Top Spot in Upper Midsize SUV Segment2025…
Kia Announces June 2025 Global Sales Results
June 2025 global sales of 269,652 units, up 0.2% Y/yOutside of Korea,…
Kia America Posts Highest FirstHalf Sales in Company History
416,511 units sold in first six months of 2025, up 8 percent…
Aon’s 2025 Global Cyber Risk Report Reveals Reputation Risk Events Can Reduce Shareholder Value by 27 percent
DUBLIN, June 17, 2025 /PRNewswire/ --Â Aon plc (NYSE: AON), a leading global…
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9…
XRP News: Vaultro Finance Presale on XRP Ledger Sells Past 48% of Its Native Token Allocation Act Now Before It Sells Out
SINGAPORE, June 14, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has once again…
Introducing FactsR by Corti — the First Clinical Reasoning Layer for Ambient AI in Healthcare
Real-time, recursive, fact-first architecture reduces AI-generated "note bloat" by 65 percent and…